Search clinical trials for: glucagon like peptide-1

Total 740 results

Eli Lilly and Company

Completed

Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents

Diabetes Mellitus | Hypoglycemia

United States
Xeris Pharmaceuticals

Completed

Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

Hypoglycemia | Diabetes Mellitus, Type 1

United States, Canada
University of Copenhagen
Hvidovre University Hospital

Completed

Effects of Gut Peptides on Bone Remodeling (KS-3)

Healthy

Denmark
The University of Texas Health Science Center at...
South Texas Veterans Health Care System

Active, not recruiting

Effect of Physiologic Hyperglucogonemia on Adipocyte Metabolism (Glucagon)

Insulin Sensitivity

United States
Steven J. Russell, MD, PhD

Completed

Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon

Type 1 Diabetes

United States
Bayer

Active, not recruiting

An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice (FINEGUST)

Type 2 Diabetes Mellitus | Chronic Kidney Disease

Japan, Spain, Netherlands, Denmark, United States
Joslin Diabetes Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaborators

Completed

Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia

Post-bariatric Hypoglycemia

United States
Xeris Pharmaceuticals
SGS S.A.; Integrated Medical Development

Completed

G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes

Type 1 Diabetes Mellitus | Severe Hypoglycemia | Insulin Hypoglycemia

United States, Canada
Xeris Pharmaceuticals
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients

Hypoglycemia | Complications of Bariatric Procedures

United States
Biodel

Completed

Pharmacokinetics and Pharmacodynamics of BIOD-961 vs. Marketed Glucagons

Hypoglycemia
University Health Network, Toronto

Completed

Acute Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon (Glucagon)

Diabetes

Canada
Xeris Pharmaceuticals

Completed

Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric Surgery

Hyperinsulinemic Hypoglycemia

United States
Hvidovre University Hospital
Technical University of Denmark

Completed

The Impact of Subcutaneous Glucagon Before, During and After Exercise a Study in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Denmark
Zealand Pharma

Completed

ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon

Diabetes Mellitus Type 1

Germany
Eli Lilly and Company

Completed

A Study Comparing User Experience of Different Delivery Devices for Glucagon

Healthy

United States
AdventHealth Translational Research Institute

Active, not recruiting

Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects (GIO B)

Obesity

United States
Xeris Pharmaceuticals

Completed

G-Pen™ for Hypoglycemia Rescue in T1D Patients

Hypoglycemia

United States
Xeris Pharmaceuticals
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism

Congenital Hyperinsulinism

United States
Xeris Pharmaceuticals
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Emissary...

Completed

Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes

Hypoglycemia

United States
Stanford University
University of Virginia; DexCom, Inc.; The Leona M. and Harry B. Helmsley Charitable...

Completed

Testing State of the Art Remote Glucose Monitoring at Diabetes Camp

Type 1 Diabetes

United States
Novo Nordisk A/S

Active, not recruiting

A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight

Obesity | Diabetes Mellitus, Type 2

United States, Canada, Hungary, Portugal, Slovakia, South Africa, Poland, Bulgaria
Xeris Pharmaceuticals
The Emmes Company, LLC

Completed

Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients

Diabetes Mellitus, Type 1

United States
Janssen Research & Development, LLC

Completed

Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM)

Diabetes Mellitus, Type 2

United States
Novo Nordisk A/S

Active, not recruiting

A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease

Alzheimers Disease

United States, Canada, Italy, Sweden, Denmark, Switzerland
Eli Lilly and Company
Locemia Solutions ULC

Completed

Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia (AMG102)

Hypoglycemia

Canada
Novo Nordisk A/S

Active, not recruiting

A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP) (STEP UP)

Obesity

United States, Czechia, Germany, Canada, Hungary, Portugal, Norway, South Africa, Poland, Greece, Bulgaria, Slovakia
Mahmoud Ahmed Ali Ahmed

Completed

Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin

Psoriasis

Egypt
Novo Nordisk A/S

Active, not recruiting

DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in Italy (DOORS)

Diabetes Mellitus, Type 2

Italy
Novo Nordisk A/S

Completed

A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III

Healthy Participants

Canada
Novo Nordisk A/S

Completed

Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range (OASIS 4)

Obesity | Overweight

Germany, United States, Canada, Poland
Novo Nordisk A/S

Completed

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical Practice

Diabetes Mellitus, Type 2

Mexico
Novo Nordisk A/S

Enrolling by invitation

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Finland, as Part of Local Clinical Practice (PIONEER REAL)

Diabetes Mellitus, Type 2

Finland, France
Novo Nordisk A/S

Completed

Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes

Diabetes Mellitus, Type 2

Chile
Methodist Health System

Not yet recruiting

Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy

Polycystic Ovary Syndrome

United States
Novo Nordisk A/S

Completed

A Research Study Comparing the Effect of Different Dosing Conditions on Blood Levels of Semaglutide in a New Tablet Composition in Healthy Participants

Healthy Participants

Germany
Xeris Pharmaceuticals
Integrated Medical Development

Terminated

Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses

Diabetes Mellitus, Type 1 | Hypoglycemia Unawareness

United States
Massachusetts General Hospital
Joslin Diabetes Center

Completed

Post Bariatric Closed Loop Glucagon Trial

Hypoglycemia

United States
Papworth Hospital NHS Foundation Trust

Completed

The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure

Heart Failure

United Kingdom
University of Copenhagen
Copenhagen University Hospital, Hvidovre

Recruiting

Co-infusion of Neurotensin and GLP-1 Effects on Appetite and Food Intake.

Obesity

Denmark
Novo Nordisk A/S

Recruiting

A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range (STEP12)

Obesity | Overweight

China, Taiwan
Novo Nordisk A/S

Recruiting

A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight (STEP Young)

Obesity

Belgium, United Kingdom, Denmark, United States, Sweden, Portugal, Austria, Germany, Israel, Mexico
National Institute of Allergy and Infectious Diseases...
The University of Texas Health Science Center, Houston

Completed

Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)

HIV Infections | Non-Alcoholic Fatty Liver Disease

United States, Brazil
Darier

Unknown

Safety and Efficacy Comparison of Minocycline Microgranules Versus Lymecycline in the Treatment of Mild to Moderate Acne (MXMIN-001)

Mild to Moderate Acne

Mexico
Eli Lilly and Company
Locemia Solutions ULC

Completed

A Study of Glucagon Administered in Different Forms and Routes to Healthy Adults

Healthy

Canada
University Hospital, Gentofte, Copenhagen

Completed

The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea (HNF1A-Clamp)

Maturity-Onset Diabetes of the Young, Type 3

Denmark
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity

Obesity | Type 2 Diabetes

China
Novo Nordisk A/S

Enrolling by invitation

Real-world Study of CHina Ozempic cLinicAl pRactice in Patients With Type 2 Diabetes (SCHOLAR) (SCHOLAR)

Diabetes Mellitus, Type 2

China
Hvidovre University Hospital

Completed

Incretin Hormone Antagonism After Bariatric Surgery (INCA-BAR)

Bariatric Surgery

Denmark
Novo Nordisk A/S

Not yet recruiting

Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

Diabetes Mellitus, Type 2
Novo Nordisk A/S

Recruiting

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) (ESSENCE)

Non-alcoholic Steatohepatitis

United States, Korea, Republic of, Australia, Taiwan, Italy, Israel, Canada, Netherlands, Czechia, Malaysia, Spain, Denmark, China, United Kingdom, Singapore, Japan, Puerto Rico, Portugal, Switzerland, Ireland, Belgium, Romania, Ger... and more

3

Subscribe